Beihai Gofar Marine Biological Industry Co Ltd (600538.SS) stock: key figures, P/E, revenue and dividend
Materials · Fertilizers & Agricultural Chemicals · China · ISIN CNE000001DD2
Beihai Gofar Marine Biological Industry Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 340.47 m CNY | 328.24 m CNY |
| Gross profit | 85.78 m CNY | 73.75 m CNY |
| Operating income | -91.69 m CNY | -23.13 m CNY |
| EBIT | -89.51 m CNY | -82.33 m CNY |
| Net income | -93.85 m CNY | -87.62 m CNY |
| Diluted EPS – continuing operations | -0.18 CNY | -0.17 CNY |
Full history since 1999, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Beihai Gofar Marine Biological Industry Co Ltd
Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, distributes pharmaceutical products in China. It operates through Pharmaceutical Distribution; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails pharmaceutical products through hospitals, clinics, other medical institutions, pharmacies, health centers, clinics, directly operated stores, general agents, distributors, and allocations. It also provides pearl eye drops, pearl powder, and pearl layer powder under the Haibao brand; brand gastrointestinal granules, honeysuckle oral solution, and children's syrup under the Guofa brand; and traumatic injury medicated wine, and sea snake medicated wine under the Haima brand. In addition, the company produces and sells forensic DNA testing equipment, reagents, and consumables; and provides technical services, including DNA testing services. Further, it engages in culture and arts activities; and provision of technical services. The company was formerly known as Beihai Gofar Marine Biological Industry Co., Ltd. and changed its name to Beihai Gofar Chuanshan Biological Co., Ltd. in June 2021. Beihai Gofar Chuanshan Biological Co., Ltd. was incorporated in 1993 and is headquartered in Beihai, China.
More stocks
- Unifique Telecomunicações S.A. (FIQE3.SA)
- Univanich Palm Oil Public Company Limited (UVAN.BK)
- Grand Korea Leisure Co. Ltd (114090.KS)
- Seah Holdings (058650.KS)
- FRP HOLDINGS, INC. (FRPH)
- Repay Holdings Corp (RPAY)
- Waterstone Financial, Inc. (WSBF)
- Aekyung Petrochemical Co Ltd (161000.KS)
- ARTS Group Co Ltd (603017.SS)
- Zhejiang Wanfeng Chemical Co. Ltd. A (603172.SS)
- Shenzhen Bioeasy Biotechnology Co. Ltd. (300942.SZ)
- NLI HOLDINGS, INC. (NL)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.